INTACT (INcision-less TArgeted Core Tissue) biopsy procedure for perinatal autopsy: initial feasibility.
To determine the feasibility and tissue yield from a perinatal incision-less ultrasound guided biopsy procedure, in the context of a 'minimally invasive autopsy' (MIA). Perinatal cases that consented for MIA underwent post-mortem MRI and 'INcisionless TArgeted Core Tissue' (INTACT) biopsy procedure, defined as organ needle biopsy via the umbilical cord performed under ultrasound guidance. Three cores of tissue were obtained from 7 target organs for each case (both lungs, both kidneys, heart, spleen and liver). Biopsy success rate was pre-defined as an adequate volume of the intended target organ for pathological analysis, judged by a pathologist blinded to the case and biopsy procedure. Thirty fetuses underwent organ sampling. The mean gestational age was 30 weeks (18-40 weeks) and mean delivery to biopsy time was 12 days (6-22 days). The overall success rate was 153/201 samples (76.1%), with success rates of individual organs highest for heart and lungs (93%, 92% respectively) and lowest for spleen (11%). Excluding splenic samples, the biopsy success rate would have been 150/173 (86.7%). Histological abnormalities were found in 4/201 (2%) samples - in the lungs and kidneys of a fetus with pulmonary hypoplasia and multicystic kidney disease. Incision-less ultrasound guided organ biopsies are feasible, with overall success rates of >75%. This novel INTACT technique offers the ideal combination of an imaging-led autopsy with organ sampling for parents who decline the conventional invasive approach. This article is protected by copyright. All rights reserved.